BMRN - BioMarin Pharmaceutical Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$90.94
DETAILS
HIGH:
$124.00
LOW:
$59.00
MEDIAN:
$90.00
CONSENSUS:
$90.94
UPSIDE:
36.69%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Halvorsen | 7,616,563 | $435.8M | 1.2% | +554,486 | INCREASED |
| Dalio | 274,911 | $15.7M | 0.1% | +68,000 | INCREASED |
| Cooperman | 92,214 | $5.3M | 0.0% | -190,246 | DECREASED |
| Greenblatt | 28,641 | $1.6M | 0.0% | -145,450 | DECREASED |
| Wood | 0 | $0 | -- | -100,000 | SOLD |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-09-02 | Davis George Eric | officer: EVP, Chief Legal Officer | SELL | 17,557 | $66.28 | $1.2M |
| 2026-06-02 | Countouriotis Athena | director | A-Award | 7,490 | -- | -- |
| 2026-06-02 | Walbert Timothy P | director | A-Award | 7,490 | -- | -- |
| 2026-06-02 | Ho Maykin | director | A-Award | 7,490 | -- | -- |
| 2026-06-02 | Enyedy Mark J | director | A-Award | 7,490 | -- | -- |
| 2026-06-02 | Dere Willard H | director | A-Award | 7,490 | -- | -- |
| 2026-06-02 | CLARK IAN T | director | A-Award | 7,490 | -- | -- |
| 2026-06-02 | HOMBACH ROBERT J. | director | A-Award | 7,490 | -- | -- |
| 2026-06-02 | Bodem Barbara W. | director | A-Award | 7,490 | -- | -- |
| 2026-06-02 | ANDERSON ELIZABETH M | director | A-Award | 7,490 | -- | -- |
| 2026-05-20 | Hubbard Cristin | officer: EVP, Chief Commercial Officer | F-InKind | 2,318 | $50.20 | $116K |
| 2026-05-07 | Friberg Gregory R | officer: EVP, Chief R&D Officer | SELL | 3,281 | $53.85 | $177K |
| 2026-03-17 | Hardy Alexander | director, officer: Chief Executive Officer | F-InKind | 4,252 | $56.05 | $238K |
| 2026-03-17 | Mueller Brian | officer: EVP, Chief Financial Officer | F-InKind | 2,117 | $56.05 | $119K |
| 2026-03-18 | Davis George Eric | officer: EVP, Chief Legal Officer | F-InKind | 1,273 | $56.05 | $71K |
| 2026-03-17 | Guyer Charles Greg | officer: EVP, Chief Technical Officer | F-InKind | 1,693 | $56.05 | $95K |
| 2026-03-16 | Hubbard Cristin | officer: EVP, Chief Commercial Officer | A-Award | 15,410 | -- | -- |
| 2026-03-16 | Friberg Gregory R | officer: EVP, Chief R&D Officer | A-Award | 19,150 | -- | -- |
| 2026-03-17 | Friberg Gregory R | officer: EVP, Chief R&D Officer | F-InKind | 1,629 | $56.05 | $91K |
| 2026-03-17 | Hubbard Cristin | officer: EVP, Chief Commercial Officer | F-InKind | 1,245 | $56.05 | $70K |
| 2026-03-16 | Hubbard Cristin | officer: EVP, Chief Commercial Officer | A-Award | 36,680 | $57.43 | $2.1M |
| 2026-03-16 | Friberg Gregory R | officer: EVP, Chief R&D Officer | A-Award | 45,600 | $57.43 | $2.6M |
| 2026-03-16 | Davis George Eric | officer: EVP, Chief Legal Officer | F-InKind | 7,177 | $58.51 | $420K |
| 2026-03-16 | Guyer Charles Greg | officer: EVP, Chief Technical Officer | A-Award | 14,990 | -- | -- |
| 2026-03-16 | Davis George Eric | officer: EVP, Chief Legal Officer | A-Award | 14,570 | -- | -- |